CIK 0001821825
- Large accelerated filer
Organon & Co.
Sign in to watch- Ticker
- OGN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 464838035
- Phone
- +1 551-430-6000
- Business address
- 30 HUDSON STREET, FL 33, JERSEY CITY, NJ, 07302
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | WALSH MATTHEW M Chief Financial Officer | Exercise or conversion | +12,047 | 202,707 | ||
| 2026-03-31 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −4,127 | $5.70 | $24K | 198,580 |
| 2026-03-31 | WALSH MATTHEW M Chief Financial Officer | Exercise or conversion | +21,546 | 220,126 | ||
| 2026-03-31 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −7,380 | $5.70 | $42K | 212,746 |
| 2026-03-31 | WALSH MATTHEW M Chief Financial Officer | Grant or award · Restricted Stock Units | +321,368 | 321,368 | ||
| 2026-03-31 | WALSH MATTHEW M Chief Financial Officer | Grant or award · Restricted Stock Units | +83,472 | 83,472 | ||
| 2026-03-31 | WALSH MATTHEW M Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −12,047 | 0 | ||
| 2026-03-31 | WALSH MATTHEW M Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −21,546 | 43,094 | ||
| 2026-03-29 | WALSH MATTHEW M Chief Financial Officer | Exercise or conversion | +15,071 | 195,822 | ||
| 2026-03-29 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −5,162 | $5.84 | $30K | 190,660 |
| 2026-03-29 | WALSH MATTHEW M Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −15,071 | 15,071 | ||
| 2026-02-27 | WALSH MATTHEW M Chief Financial Officer | Grant or award | +42,599 | 187,083 | ||
| 2026-02-27 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −14,887 | $7.17 | $107K | 172,196 |
| 2026-02-27 | WALSH MATTHEW M Chief Financial Officer | Grant or award | +12,020 | 184,216 | ||
| 2026-02-27 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −4,117 | $7.23 | $30K | 180,751 |
| 2025-05-05 | WALSH MATTHEW M Chief Financial Officer | Purchase | +11,400 | $8.82 | $101K | 144,484 |
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Exercise or conversion | +15,070 | 130,458 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −7,422 | $14.51 | $108K | 123,036 |
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Exercise or conversion | +12,046 | 135,082 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −5,933 | $14.51 | $86K | 129,149 |
Page 1 of 4 · 61 trades